All Archives - Page 5 of 15

All

Salvina Therapeutics joins BaseLaunch portfolio

Salvina Therapeutics AG, a recently founded Swiss company, is developing new therapies to break efficacy ceilings in inflammatory and autoimmune diseases. The company has unlocked…

andy02.10.2023

All Featured Portfolio news

TOLREMO therapeutics secures USD 39 million

Basel, 20 September, 2023 – The Swiss biotech company TOLREMO therapeutics AG recently completed a successful Series A financing, bringing the total amount raised to…

andy21.09.2023

All Featured Portfolio news

Alentis Therapeutics receives FDA Fast Track Designation for ALE.C04

We are pleased to announce that Alentis Therapeutics, a company within our portfolio, has been granted fast track designation by the US FDA for its…

isabelletaureck13.09.2023

All Features

What you need to know about building your biotech startup

What you need to know about building your biotech startup What do biotech entrepreneurs need to navigate the biotech landscape successfully? In the ”Beyond biotech”…

andy13.09.2023

All Features

BaseLaunch Summer Get-Together 2023

We are very pleased to have had so many experts, partners, and friends joining our Summer Get-together this year! It was an incredible day filled…

Martyna Wroblewska04.08.2023

All Featured Portfolio news

Versameb strengthens its Board of Directors

Versameb, transforming (m)RNA therapeutics to cure hard-to-treat and/or prevalent diseases, is pleased to announce the appointments of Hernán Levett, Dr Lily Geidelberg, Paul Korner, MD,…

Martyna Wroblewska12.07.2023

All Featured Portfolio news

Cimeio Therapeutics and Prime Medicine announce research collaboration

Our portfolio company, Cimeio Therapeutics, a biotechnology company that is reinventing cell therapy through its leadership in the emerging field of epitope shielding, and Prime…

Martyna Wroblewska22.06.2023

All Features

How Swiss life sciences startups can compete globally

How Swiss life sciences startups can compete globally In this biotech networking event, Johnson & Johnson Innovation shared their approach towards external innovation and their…

Martyna Wroblewska06.06.2023

All Features

Bridge Biotherapeutics’ partnering strategy and growth by external innovation

Bridge Biotherapeutics’ partnering strategy and growth by external innovation In this biotech networking event, two speakers from Bridge Biotherapeutics talked about the history of their…

Martyna Wroblewska25.05.2023

All Featured Portfolio news

Phialogics AG appoints Prof. Dr. Erich Schlick as Chairman of its Board of Directors

Phialogics AG has announced the appointment of Prof. Dr. Erich Schlick as Chairman of its Board of Directors. Erich was introduced to Phialogics by BaseLaunch…

Martyna Wroblewska12.05.2023

All

Salvina Therapeutics joins BaseLaunch portfolio

TOLREMO therapeutics secures USD 39 million

Alentis Therapeutics receives FDA Fast Track Designation for ALE.C04

What you need to know about building your biotech startup

BaseLaunch Summer Get-Together 2023

Versameb strengthens its Board of Directors

Cimeio Therapeutics and Prime Medicine announce research collaboration

How Swiss life sciences startups can compete globally

Bridge Biotherapeutics’ partnering strategy and growth by external innovation

Phialogics AG appoints Prof. Dr. Erich Schlick as Chairman of its Board of Directors

Useful links

Contact us

Sign up for our newsletter and event invitations

Follow us